Real-World Data and Real-World Evidence (RWD/RWE) have been utilized not only for drug safety assessment but also for efficacy evaluation for drug approval at global basis. Over the years, many real ...
Critical Path Institute® today announced that its Translational Therapeutics Accelerator program, in partnership with The Leona M. and Harry B. Helmsley Charitable Trust, a new research grant aimed at ...
At present, olverembatinib has been approved in China for the treatment of adult patients with TKI-resistant chronic-phase chronic myeloid leukemia (CML-CP) or accelerated-phase CML (CML-AP) harboring ...